Mills KH - Search Results

1

Byrne WL, Mills KH, Lederer JA, O'Sullivan GC. Byrne WL, et al. Among authors: mills kh. Cancer Res. 2011 Nov 15;71(22):6915-20. doi: 10.1158/0008-5472.CAN-11-1156. Epub 2011 Nov 8. Cancer Res. 2011. PMID: 22068034 Free PMC article. Review.

2

Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.

Marshall NA, Galvin KC, Corcoran AM, Boon L, Higgs R, Mills KH. Marshall NA, et al. Among authors: mills kh. Cancer Res. 2012 Feb 1;72(3):581-91. doi: 10.1158/0008-5472.CAN-11-0307. Epub 2011 Dec 9. Cancer Res. 2012. PMID: 22158905

3

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells.

Conroy H, Galvin KC, Higgins SC, Mills KH. Conroy H, et al. Among authors: mills kh. Cancer Immunol Immunother. 2012 Mar;61(3):425-31. doi: 10.1007/s00262-011-1188-y. Epub 2011 Dec 23. Cancer Immunol Immunother. 2012. PMID: 22193988 Free PMC article.

4

Blocking retinoic acid receptor-α enhances the efficacy of a dendritic cell vaccine against tumours by suppressing the induction of regulatory T cells.

Galvin KC, Dyck L, Marshall NA, Stefanska AM, Walsh KP, Moran B, Higgins SC, Dungan LS, Mills KH. Galvin KC, et al. Among authors: mills kh. Cancer Immunol Immunother. 2013 Jul;62(7):1273-82. doi: 10.1007/s00262-013-1432-8. Epub 2013 May 9. Cancer Immunol Immunother. 2013. PMID: 23657628 Free PMC article.

5

Anti-PD-1 inhibits Foxp3⁺ Treg cell conversion and unleashes intratumoural effector T cells thereby enhancing the efficacy of a cancer vaccine in a mouse model.

Dyck L, Wilk MM, Raverdeau M, Misiak A, Boon L, Mills KH. Dyck L, et al. Among authors: mills kh. Cancer Immunol Immunother. 2016 Dec;65(12):1491-1498. doi: 10.1007/s00262-016-1906-6. Epub 2016 Sep 28. Cancer Immunol Immunother. 2016. PMID: 27680570 Free PMC article.

6

Regulatory cells and the control of respiratory infection.

McGuirk P, Higgins SC, Mills KH. McGuirk P, et al. Among authors: mills kh. Curr Allergy Asthma Rep. 2005 Jan;5(1):51-5. doi: 10.1007/s11882-005-0054-4. Curr Allergy Asthma Rep. 2005. PMID: 15659263 Review.

7

Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.

Jarnicki AG, Lysaght J, Todryk S, Mills KH. Jarnicki AG, et al. Among authors: mills kh. J Immunol. 2006 Jul 15;177(2):896-904. doi: 10.4049/jimmunol.177.2.896. J Immunol. 2006. PMID: 16818744

8

Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.

Jarnicki AG, Conroy H, Brereton C, Donnelly G, Toomey D, Walsh K, Sweeney C, Leavy O, Fletcher J, Lavelle EC, Dunne P, Mills KH. Jarnicki AG, et al. Among authors: mills kh. J Immunol. 2008 Mar 15;180(6):3797-806. doi: 10.4049/jimmunol.180.6.3797. J Immunol. 2008. PMID: 18322186

9

CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.

Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KH. Fletcher JM, et al. Among authors: mills kh. J Immunol. 2009 Dec 1;183(11):7602-10. doi: 10.4049/jimmunol.0901881. Epub 2009 Nov 16. J Immunol. 2009. PMID: 19917691

10

The role of regulatory T cells in respiratory infections and allergy and asthma.

McGuirk P, Higgins SC, Mills KH. McGuirk P, et al. Among authors: mills kh. Curr Allergy Asthma Rep. 2010 Jan;10(1):21-8. doi: 10.1007/s11882-009-0078-2. Curr Allergy Asthma Rep. 2010. PMID: 20425510 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page